| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0017 |
1 |
| mRNA |
Topotecan |
FIMM |
pan-cancer |
AAC |
0.0045 |
1 |
| mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
0.0016 |
1 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0012 |
1 |
| mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
0.002 |
1 |
| mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
-0.01 |
1 |
| mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
-0.0012 |
1 |
| mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.0011 |
1 |
| mRNA |
GW 441756 |
GDSC1000 |
pan-cancer |
AAC |
-0.00099 |
1 |
| mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
-0.00093 |
1 |